Retreatment of nasopharyngeal carcinoma by intensity-modulated radiotherapy concurrent with weekly cetuximab

被引：0
|
作者：
Chua, D. T. T. [1 ]
Lee, V. [1 ]
Ng, S. [1 ]
机构：
[1] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
ORAL ONCOLOGY | 2009年
关键词：
D O I：
10.1016/j.oos.2009.06.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [31] Delayed clinical complete response to intensity-modulated radiotherapy in nasopharyngeal carcinoma
    Li, Wen-Fei
    Zhang, Yuan
    Liu, Xu
    Tang, Ling-Long
    Tian, Li
    Guo, Rui
    Liu, Li-Zhi
    Sun, Ying
    Ma, Jun
    ORAL ONCOLOGY, 2017, 75 : 120 - 126
  • [32] Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Penang General Hospital Experience
    Phua, Chee Ee
    Tan, Boon Seang
    Tan, Ai Lian
    Eng, Kae Yann
    Ng, Bong Seng
    Malik, Rozita Abdul
    Ishak, Wan Zamaniah Wan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) : 3287 - 3292
  • [33] Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
    Lu, TX
    Mai, WY
    Teh, BS
    Zhao, C
    Han, F
    Huang, Y
    Deng, XW
    Lu, LX
    Huang, SM
    Zeng, ZF
    Lin, CG
    Lu, HH
    Chiu, JK
    Carpenter, LS
    Grant, WH
    Woo, SY
    Cui, NJ
    Butler, EB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 682 - 687
  • [34] Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Xia, P
    Fu, KK
    Wong, GW
    Akazawa, C
    Verhey, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02): : 329 - 337
  • [35] Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
    Wu, Shixiu
    Xia, Bing
    Han, Fei
    Xie, Ruifei
    Song, Tao
    Lu, Lixia
    Yu, Wei
    Deng, Xiaowu
    He, Qiancheng
    Zhao, Cong
    Xie, Conghua
    PLOS ONE, 2015, 10 (08):
  • [36] Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience
    Lee, N
    Xia, P
    Quivey, JM
    Sultanem, K
    Poon, I
    Akazawa, C
    Akazawa, PM
    Weinberg, V
    Fu, KK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01): : 12 - 22
  • [37] Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Wei Lu Kuang
    Qin Zhou
    Liang Fang Shen
    Clinical and Translational Oncology, 2012, 14 : 783 - 790
  • [38] Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Kuang, Wei Lu
    Zhou, Qin
    Shen, Liang Fang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10): : 783 - 790
  • [39] A Phase II Study Of Concurrent Nimotuzumab And Intensity-Modulated Radiotherapy In Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
    Feng, Y.
    Cao, C.
    Jiang, F.
    Jin, Q.
    Jin, T.
    Huang, S.
    Hu, Q.
    Chen, Y.
    Piao, Y.
    Hua, Y.
    Feng, X.
    Chen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E789 - E790
  • [40] Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
    He, Yan
    Guo, Tao
    Guan, Hui
    Wang, Jingjing
    Sun, Yu
    Peng, Xingchen
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1419 - 1428
12345